TRCT
ASPX

Tower Research Capital (TRC)’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Tower Research Capital (TRC)’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-664
Closed -$67K – 5637
2015
Q1 		$67K Buy
664
+564
+564% +$37.6K 0.01% 1239
2014
Q4 		$5K Sell
100
-608
-86% -$17.9K ﹤0.01% 2809
2014
Q3 		$18K Buy
708
+412
+139% +$8.77K ﹤0.01% 2419
2014
Q2 		$7K Sell
296
-1,704
-85% -$37.3K ﹤0.01% 2675
2014
Q1 		$62K Buy
+2,000
New +$53.7K 0.01% 947

Tower Research Capital (TRC)'s ASPX Position: Q2 2015 in Review

Tower Research Capital (TRC) sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 664 shares — an estimated $67K sold.

Tower Research Capital (TRC) first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $67K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Tower Research Capital (TRC) reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 664 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $67K.
  • Tower Research Capital (TRC) first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $67K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.